Table 2.
Clinical Characteristics of 14 Patients with Secondary TN
| Age/Sex | TN Duration (y) | Side | Spreading of Pain | Neurological Symptoms (Except TN) | Tumor Type | Removal of Tumor | Outcome | Complications | Follow-Up (y) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 45/F | 6 | Le | V2 | Hypesthesia a/d (V n.) | M | Total | Ex | 10 | |
| 2 | 56/M | 11 | R | V3 | E | Total | Ex | Liquorrhea | 8 | |
| 3 | 48/F | 9 | R | V2–3 | L | Subtotal | Good | Hypesthesia (V n.) | 7 | |
| 4 | 54/F | 8 | R | V3 | E | Total | Ex | Dizziness | 6 | |
| 5 | 39/F | 4 | Le | V1–2-3 | Hearing loss, hypesthesia a/d (V n.) | N | Total | Ex | 6 | |
| 6 | 62/F | 19 | R | V2–3 | E | Total | Ex | 5 | ||
| 7 | 44/M | 6 | Le | V3 | HFS | E | Total | Ex | Hearing loss | 5 |
| 8 | 28/F | 2 | Le | V2–3 | HFS | E | Total | Ex | 4 | |
| 9 | 59/F | 9 | R | V3 | Hypesthesia (V n.) | M | Total | Ex | 4 | |
| 10 | 34/M | 5 | Le | V1–2-3 | Wryneck | E | Subtotal | Good | 3 | |
| 11 | 53/F | 8 | Le | V1–2-3 | Hypesthesia a/d (V n.) | E | Total | Ex | 2 | |
| 12 | 66/F | 12 | R | V3 | E | Total | Ex | 2 | ||
| 13 | 78/F | 23 | Le | V1–2 | Dizziness | M | Total | Ex | Dizziness | 1 |
| 14 | 51/F | 11 | R | V2–3 | Dizziness | E | Subtotal | Ex | 1 |
E, epidermoid; Ex, excellent; HFS, hemifacial spasm; L, lipoma; Le, left; a\d, after alcohol destruction; M, meningioma; N, neurinoma; R, right; TN, trigeminal neuralgia.